/
GLTA
$10.73-$4.07 (-27.50%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Price (6 mo)
Loading chart…
Change+$1.03
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$1.0K | −$3.0M |
| EBITDA | $6 | −$3.0M |
| Net income | −$1.0K | $1.3M |
| Net margin | — | — |
| EPS (diluted) | -0.08 | 0.09 |
Annual figures · source: Financial Modeling Prep
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| GLTAGalata Acquisition Corp. | $10.73 | -27.50% | $193M | — |
| ALPAAlpha Healthcare Acquisition Corp. III | $9.80 | +0.10% | $194M | — |
| APMIAxonPrime Infrastructure Acquisition Corporation | $10.33 | +0.10% | $194M | — |
| ARYEARYA Sciences Acquisition Corp V | $10.36 | -0.19% | $199M | — |
| EBACEuropean Biotech Acquisition Corp. | $11.19 |
Held by traders on TradeandTell
No one on the platform currently holds GLTA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GLTA as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GLTA yet.